Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 04/02/2019
Entire Document
 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    OREXIGEN THERAPEUTICS, INC.
Date: April 2, 2019     By:  

/s/ Thomas P. Lynch

    Name:   Thomas P. Lynch
    Title:   Chief Administrative Officer, General Counsel, President, Secretary and Treasurer